Your browser doesn't support javascript.
loading
The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR).
Inchakalody, Varghese P; Hydrose, Shereena P; Krishnankutty, Roopesh; Merhi, Maysaloun; Therachiyil, Lubna; Sasidharan Nair, Varun; Elashi, Asma A; Khan, Abdul Q; Taleb, Sara; Raza, Afsheen; Yoosuf, Zeenath Safira K M; Fernandes, Queenie; Al-Zaidan, Lobna; Mestiri, Sarra; Taib, Nassiba; Bedhiafi, Takwa; Moustafa, Dina; Assami, Laila; Maalej, Karama Makni; Elkord, Eyad; Uddin, Shahab; Al Homsi, Ussama; Dermime, Said.
Afiliação
  • Inchakalody VP; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Hydrose SP; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Krishnankutty R; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Merhi M; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Therachiyil L; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; College of Pharmacy, Qatar University, Doha, Qatar.
  • Sasidharan Nair V; Department of Experimental Immunology, Helmholtz Centre for Infection Research, Germany.
  • Elashi AA; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Khan AQ; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar.
  • Taleb S; Genomics and Precision Medicine, Hamad Bin Khalifa University, Doha, Qatar.
  • Raza A; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Yoosuf ZSKM; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar; College of Health and Life Sciences, Hamad Bin Khalifa University, Doha, Qatar.
  • Fernandes Q; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar; College of Medicine, Qatar University, Doha, Qatar.
  • Al-Zaidan L; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Mestiri S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Taib N; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Bedhiafi T; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Moustafa D; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Assami L; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Maalej KM; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Elkord E; Natural and Medical Sciences Research Center, University of Nizwa, Oman; Biomedical Research Center, School of Science, Engineering and Environment, University of Salford, Manchester, UK.
  • Uddin S; Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, Qatar; Translational Research Institute and Dermatology Institute, Academic Health System, Doha, Qatar.
  • Al Homsi U; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar.
  • Dermime S; National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar; Translational Cancer Research Facility, Interim Translational Research Institute, Hamad Medical Corporation, Doha, Qatar. Electronic address: sdermime@hamad.qa.
Eur J Pharmacol ; 945: 175612, 2023 Apr 15.
Article em En | MEDLINE | ID: mdl-36822455
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Epigênese Genética / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Qatar
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Assunto principal: Epigênese Genética / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Qatar